Jastreboff, A.M., Aronne, L.J., Ahmad, N.N., et al
Da Porto A, Casarsa V, Colussi G, Catena C, Cavarape A, Sechi L (2020) Dulaglutide reduces binge episodes in type 2 diabetic patients with binge-eating disorder: a pilot study
If you have been harmed by taking Ozempic, Wegovy, or any other GLP-1 drugs, our dedicated team is here to assist you
Not intended for human consumption or medical use
Semaglutide GLP-1 is typically administered once a week through an injection, providing a simple and consistent treatment plan
These widespread clinical benefits have led to a surge in patient uptakeand higher prescription drug spending by commercial insurers and state Medicaid agencies